High-Content Imaging Analysis of the Knockdown Effects of Validated siRNAs and Antisense Oligonucleotides

This publication has 22 references indexed in Scilit:

• Prospects of RNA interference therapy in respiratory viral diseases: update 2006
  Expert Opinion on Biological Therapy, 2006
• Small interfering RNA targeting epidermal growth factor receptor enhances chemosensitivity to cisplatin, 5‐fluorouracil and docetaxel in head and neck squamous cell carcinoma
  Cancer Science, 2006
• Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1
  Gene Therapy, 2005
• Bcl-2 Antisense Oligonucleotide Overcomes Resistance toE1AGene Therapy in a Low HER2-Expressing Ovarian Cancer Xenograft Model
  Cancer Research, 2005
• A Phase I Pharmacokinetic and Pharmacodynamic Study of OGX-011, a 2′-Methoxyethyl Antisense Oligonucleotide to Clusterin, in Patients With Localized Prostate Cancer
  JNCI Journal of the National Cancer Institute, 2005
• Direct comparison of the specificity of gene silencing using antisense oligonucleotides and RNAi
  Biochemical Journal, 2005
• A Quantitative Cell-Based High-Content Screening Assay for the Epidermal Growth Factor Receptor-Specific Activation of Mitogen-Activated Protein Kinase
  ASSAY and Drug Development Technologies, 2004
• Applying Antisense Technology
  Annals of the New York Academy of Sciences, 2003
• Advances in High Content Screening for Drug Discovery
  ASSAY and Drug Development Technologies, 2003
• Novel Antisense and Peptide Nucleic Acid Strategies for Controlling Gene Expression
  Biochemistry, 2002